Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Dabomb Protein Biotech Corporation (6578) Financial Statements

Dabomb Protein Biotech Corporation Financial Overview

Dabomb Protein Biotech Corporation's market cap is currently NT$1.21B. The company's EPS TTM is NT$-0.57; its P/E ratio is -51.66; and it has a dividend yield of 2.37%. Dabomb Protein Biotech Corporation has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 309.33MNT$ 337.82MNT$ 384.41MNT$ 433.63MNT$ 470.63M
Gross ProfitNT$ 69.03MNT$ 68.73MNT$ 46.43MNT$ 19.33MNT$ 21.65M
Operating IncomeNT$ -28.18MNT$ -1.82MNT$ -29.93MNT$ -42.48MNT$ -67.04M
EBITDANT$ -22.25MNT$ 34.98MNT$ -26.00MNT$ -15.49MNT$ -40.80M
Net IncomeNT$ -69.34MNT$ 11.64MNT$ -57.02MNT$ -44.66MNT$ -62.45M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 160.63MNT$ 304.98MNT$ 429.45MNT$ 232.01MNT$ 266.87M
Total AssetsNT$ 1.10BNT$ 1.32BNT$ 1.40BNT$ 1.28BNT$ 1.34B
Total DebtNT$ 74.21MNT$ 168.53MNT$ 418.00MNT$ 496.04MNT$ 618.30M
Net DebtNT$ -57.96MNT$ -85.05MNT$ 38.02MNT$ 300.87MNT$ 421.17M
Total LiabilitiesNT$ 106.48MNT$ 225.96MNT$ 443.83MNT$ 552.88MNT$ 662.24M
Stockholders' EquityNT$ 989.28MNT$ 1.09BNT$ 958.06MNT$ 727.20MNT$ 674.24M
Cash Flow
Free Cash FlowNT$ -21.04MNT$ 17.23MNT$ -12.37MNT$ -449.00KNT$ -376.35M
Operating Cash FlowNT$ 16.65MNT$ 47.55MNT$ 6.51MNT$ 19.71MNT$ -44.25M
Investing Cash FlowNT$ -14.42MNT$ -31.48MNT$ -31.89MNT$ 12.96MNT$ -382.75M
Financing Cash FlowNT$ -122.84MNT$ -139.75MNT$ 208.85MNT$ -34.15MNT$ 356.71M

Currency in TWD

Dabomb Protein Biotech Corporation Earnings and Revenue History

-400M0400M800M-24 %-12 %0 %12 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Dabomb Protein Biotech Corporation Liabilities to Assets

0500M1B1.5B0 %20 %40 %60 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Dabomb Protein Biotech Corporation Cash Flow

-600M-400M-200M0200M400M2019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Dabomb Protein Biotech Corporation Forecast EPS vs Actual EPS

-0.8-0.6-0.4-0.200.20.4Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss
Earnings >